TVRD Tvardi Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 10-K/10-Q 八月 14, 2026
$0.94
· % 处于52周区间
· 高于低点
· 至高点
$0.9352周低点
$5.6952周高点
市值 (MRQ)
$9M
P/E
-0.3
EPS
$-3.26
收入
$7M
TVRD 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.94
市值 (MRQ)
$9M
P/E
-0.3
EPS
$-3.26
收入
$7M
ROE
-67.6%
52周区间
$1–$6
TVRD 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2025年4月16日 | 1-for-3 | 反向 |
| 2024年12月31日 | 1-for-12 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$7M2016-12-31 → 2024-12-31
EPS$-3.262018-12-31 → 2025-12-31
自由现金流·2016-12-31 → 2024-12-31
净利率·2016-12-31 → 2024-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | TVRD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -0.35年均值 ≈-55.2 | ≈-55.2 | · | · | |
| P/S | 1.15年均值 ≈320.3 | ≈320.3 | 10.1 | 低估 | |
| 市净率 (MRQ) | 1.15年均值 ≈48.6 | ≈48.6 | 2.1 | 公允价值 | |
| Price / Cash Flow (市现率) | -0.45年均值 ≈-134.7 | ≈-134.7 | · | · | |
| 市净率（有形资产） (MRQ) | 1.15年均值 ≈78.7 | ≈78.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | TVRD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -54.1%5年均值 ≈-57.7% | ≈-57.7% | -54.1% | 持平 | |
| ROE | -67.6%5年均值 ≈-30.7% | ≈-30.7% | -67.6% | 持平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | TVRD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 1.95年均值 ≈7.1 | ≈7.1 | 1.9 | 持平 | |
| Quick Ratio (速动比率) | 2.85年均值 ≈3.6 | ≈3.6 | 1.7 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | TVRD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -66.0%5年均值 ≈-29.3% | ≈-29.3% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -32.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | TVRD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$594.8K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-119.0%
下次报告
十一月 12, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 14, 2026 | $-0.69 | $-0.72 | 3.9% |
| 2026年3月31日 | 五月 19, 2026 | $-0.73 | $-0.76 | 3.8% |
| 2025年12月31日 | $-0.78 | $-0.66 | -18.3% | |
| 2025年9月30日 | $-0.59 | $-1.02 | 42.1% | |
| 2025年6月30日 | $-1.00 | $-0.58 | -71.4% | |
| 2025年3月31日 | $-3.22 | $-0.36 | -802.0% | |
| 2024年9月30日 | $-8.28 | $-9.06 | 8.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $7M | $21M | $42M | $23M | $135M | $20M | $13M | $911.0K | $86.0K | $4M | $3M | |
| Cost of Revenue | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| R&D Expense | $18M | $24M | $109M | $92M | $83M | $108M | $114M | $76M | $49M | $49M | $21M | $15M | |
| SG&A Expense | $9M | $4M | $28M | $30M | $29M | $22M | $18M | $15M | $12M | $9M | $8M | $6M | |
| Operating Expenses | $27M | $28M | $142M | $129M | $112M | $130M | $132M | $91M | $60M | $58M | $29M | $21M | |
| Operating Income | $-27M | $-28M | $-121M | $-88M | $-89M | $5M | $-112M | $-77M | $-59M | $-58M | $-25M | $-18M | |
| Interest Income | $700.0K | $700.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $7M | $-2M | $4M | $2M | $642.0K | $2M | $4M | $3M | $1M | $652.0K | $101.0K | $126.0K | |
| Pretax Income | · | $-71M | $-119M | $-85M | $-88M | $8M | $-107M | $-74M | $-58M | $-58M | $-25M | $-18M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $-691.0K | $-816.0K | $-389.0K | $-204.0K | $-468.0K | $-397.0K | $-201.0K | |
| Net Income | $-18M | $-29M | $-119M | $-85M | $-88M | $8M | $-106M | $-74M | $-58M | $-57M | $-25M | $-18M | |
| EPS (Basic) | $-2.46 | $-11.42 | $-26.26 | $-19.12 | $-1.74 | $0.18 | $-2.49 | $-2.06 | · | · | · | · | |
| EPS (Diluted) | $-3.26 | $-11.42 | $-26.26 | $-19.12 | $-1.74 | $0.18 | $-2.49 | $-2.06 | · | · | · | · | |
| Shares (Basic) | 7,419,060 | 2,574,233 | 4,512,422 | 4,471,130 | 50,718,765 | 47,413,250 | 42,669,333 | 35,892,786 | 31,202,842 | 27,279,008 | 24,620,372 | 20,965,935 | |
| Shares (Diluted) | 7,783,182 | 2,574,233 | 4,512,422 | 4,471,130 | 50,718,765 | 47,915,030 | 42,669,333 | 35,892,786 | 31,202,842 | 27,279,008 | 24,620,372 | 20,965,935 | |
| EBITDA | $-27M | $-58M | $-121M | $-87M | $-89M | $6M | $-111M | $-77M | $-59M | $-57M | $-24M | $-17M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $32M | $52M | $64M | $13M | $32M | $18M | $15M | $9M | $12M | $15M | $53M | |
| Short-term Investments | $10M | · | · | · | · | · | · | · | · | $46M | $92M | · | |
| Receivables | · | $407.0K | $3M | $3M | · | · | · | · | · | · | · | · | |
| Inventory | · | $900.0K | $3M | $2M | $3M | · | · | · | · | · | · | · | |
| Prepaid Expense | $727.0K | $72.0K | $8M | $16M | $3M | $12M | $9M | $5M | $2M | $2M | $2M | $287.0K | |
| Current Assets | $32M | $32M | $116M | $169M | $173M | $195M | $166M | $168M | $95M | $61M | $109M | $53M | |
| PP&E (Net) | $52.0K | $84.0K | $3M | $426.0K | $631.0K | $840.0K | $700.0K | $880.0K | $1M | $2M | $1M | $2M | |
| PP&E (Gross) | · | · | $5M | $2M | $2M | $2M | $2M | $2M | $2M | $10M | $8M | $8M | |
| Accum. Depreciation | · | · | $2M | $1M | $1M | $2M | $1M | $1M | $764.0K | $8M | $7M | $6M | |
| Intangibles | $322.0K | $385.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $17.0K | $17.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $32M | $35M | $126M | $182M | $247M | $271M | $233M | $191M | $97M | $64M | $111M | $56M | |
| Accounts Payable | $3M | $2M | $12M | $10M | $6M | $5M | $9M | $4M | $4M | $5M | $2M | $515.0K | |
| Accrued Liabilities | $8M | $8M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $11M | $10M | $26M | $23M | $18M | $18M | $43M | $40M | $9M | $12M | $5M | $3M | |
| Capital Leases | $85.0K | $201.0K | $6M | · | $2M | $4M | $3M | · | · | · | · | · | |
| Total Liabilities | $11M | $41M | $69M | $23M | · | · | · | · | · | · | · | · | |
| Common Stock | $9.0K | $2.0K | $5.0K | $53.0K | $53.0K | $50.0K | $47.0K | $39.0K | $33.0K | $27.0K | $27.0K | $23.0K | |
| Paid-in Capital | $131M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-110M | $-92M | $-685M | $-566M | $-481M | $-392M | $-401M | $-294M | $-220M | $-162M | $-105M | $-80M | |
| AOCI | $8.0K | · | $-260.0K | $-2M | $-358.0K | $73.0K | $170.0K | $-114.0K | $-70.0K | $3.0K | $-35.0K | $0 | |
| Stockholders' Equity | $21M | $-91M | $-62M | $159M | $228M | $249M | $187M | $134M | $87M | $51M | $105M | $52M | |
| Liabilities + Equity | $32M | $35M | $126M | $182M | $247M | $271M | $233M | $191M | $97M | $64M | $111M | $56M | |
| Shares Outstanding | 9,381,344 | 2,574,767 | 4,540,059 | 53,797,341 | 53,480,812 | 49,872,213 | 46,720,225 | 39,547,558 | 32,662,255 | 27,296,863 | 27,254,863 | 22,802,039 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $95.0K | $95.0K | $259.0K | $248.0K | $248.0K | $209.0K | $198.0K | $370.0K | $495.0K | $1M | $839.0K | $783.0K | |
| Stock-based Comp | $1M | $319.0K | $14M | $18M | $21M | $15M | $13M | $9M | $6M | $3M | $3M | $1M | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | $6M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-7M | $829.0K | $12M | $-11M | $7M | $-29M | $-16M | $42M | $-3M | $6M | $-141.0K | $-2M | |
| Operating Cash Flow | $-23M | $-18M | $-92M | $-79M | $-60M | $-5M | $-109M | $-22M | $-55M | $-47M | $-21M | $-18M | |
| CapEx | · | $1M | $2M | $43.0K | $39.0K | $349.0K | $18.0K | $73.0K | $58.0K | $717.0K | $20.0K | $42.0K | |
| Investing Cash Flow | $-10M | $49M | $43M | $129M | $-5M | $-20M | $-31M | $-83M | $-36M | $45M | · | · | |
| Stock Issued | · | · | $1M | · | · | · | $136M | $92M | $86M | · | $75M | $100.0K | |
| Net Stock Activity | · | · | $1M | · | · | · | $136M | $92M | $86M | · | · | $100.0K | |
| Financing Cash Flow | $23M | $27M | $38M | $311.0K | $47M | $39M | $143M | $111M | $88M | $123.0K | · | · | |
| Net Change in Cash | $-11M | $9M | · | · | · | · | · | · | $-3M | $-3M | $-38M | $40M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-62M | $-94M | $-79M | $-60M | $-6M | $-109M | $-22M | $-55M | $-48M | $-21M | $-18M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -818.0% | -579.4% | -209.1% | -386.9% | 4.0% | -561.6% | · | -6529.6% | -67907.0% | -662.3% | -568.8% | |
| Net Margin | · | -993.0% | -565.2% | -204.2% | -384.1% | 6.2% | -534.9% | · | -6380.4% | -66604.7% | -649.2% | -558.5% | |
| Pretax Margin | · | -998.5% | · | -204.2% | -384.1% | 5.7% | -539.0% | · | -6402.7% | -67148.8% | -659.7% | -564.9% | |
| EBITDA Margin | · | -815.3% | -578.2% | -208.5% | -385.8% | 4.1% | -560.6% | · | -6475.3% | -66203.5% | -640.3% | -544.2% | |
| ROA | -54.1% | -83.5% | -76.9% | -39.8% | -34.1% | 3.3% | -50.2% | -51.4% | -72.3% | -65.6% | -29.6% | -47.9% | |
| ROE | -67.6% | 170.6% | -166.1% | -49.8% | -40.7% | 4.5% | -53.4% | -52.3% | -62.5% | -93.5% | -22.6% | -33.2% | |
| ROIC | · | 1264.0% | · | -55.1% | -39.1% | 2.4% | -59.4% | -57.6% | -68.3% | -114.2% | -23.6% | -34.6% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 11.0 | 4.5 | 7.2 | 9.8 | 10.6 | 3.9 | 4.2 | 11.2 | 5.3 | 20.7 | 15.6 | |
| Quick Ratio | 2.8 | 9.6 | 2.1 | 2.7 | 0.8 | 1.7 | 0.4 | 0.4 | 1.1 | 5.1 | 20.3 | 15.5 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.2 | 0.1 | 0.5 | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | |
| Inventory Turnover | · | · | · | · | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | 4.5 | 7.0 | · | · | · | · | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.23 | $-1.00 | $1.05 | $2.95 | $4.25 | $4.99 | $4.00 | $3.38 | $2.66 | $1.86 | $3.85 | $2.27 | |
| Revenue / Share | · | $1.56 | $0.39 | $0.78 | $0.45 | $2.82 | $0.47 | · | $0.03 | $0.00 | $0.15 | $0.15 | |
| Cash Flow / Share | $-3.02 | $-13.35 | $-1.70 | $-1.47 | $-1.18 | $-0.11 | $-2.56 | $-0.62 | $-1.76 | $-1.74 | $-0.87 | $-0.84 | |
| Cash / Share | $2.21 | $8.29 | $0.95 | $1.18 | $0.25 | $0.64 | $0.39 | $0.38 | $0.29 | $0.44 | $0.55 | $2.31 | |
| Dividend / Share | $0.00 | · | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-3.26 | $-11.42 | $-26.26 | $-19.12 | $-1.74 | $0.18 | $-2.49 | $-2.06 | $-1.39 | $-1.39 | $-1.39 | $-1.39 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -66.0% | -49.9% | 81.8% | -83.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -32.3% | -46.3% | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $7M | $21M | $42M | $23M | $135M | $20M | $13M | $911.0K | $86.0K | $4M | $3M | |
| Net Income TTM | $-18M | $-29M | $-119M | $-85M | $-88M | $8M | $-106M | $-74M | $-58M | $-57M | $-25M | $-18M | |
| Market Cap | $40M | $84M | $1.46B | $20.80B | $23.45B | $27.16B | $27.10B | $18.51B | $14.39B | $9.13B | $16.54B | $8.18B | |
| P/E | -1.3 | -1.6 | -1.0 | -20.2 | -252.0 | 3026.0 | -232.9 | -227.2 | -317.0 | -240.6 | -436.7 | -258.2 | |
| P/S | 4.9 | 11.8 | 69.5 | 496.8 | 1018.3 | 201.1 | 1362.6 | 1374.1 | 15798.3 | 106153.1 | 4349.9 | 2576.0 | |
| P/B | 1.9 | -18.3 | 25.5 | 131.0 | 103.1 | 109.1 | 145.1 | 138.5 | 165.8 | 180.0 | 157.5 | 158.4 | |
| P / Tangible Book | 2.0 | · | · | 131.0 | 103.1 | 109.1 | · | · | · | · | · | · | |
| P / Cash Flow | -1.7 | -1.4 | -15.8 | -264.2 | -390.3 | -4950.7 | -248.1 | -829.9 | -262.5 | -192.7 | -770.2 | -463.9 | |
| P / FCF | · | -1.4 | -15.4 | -264.1 | -390.0 | -4654.6 | -248.0 | -827.2 | -262.2 | -189.8 | -769.5 | -462.8 | |
| Earnings Yield | -75.8% | -62.2% | -98.2% | -5.0% | -0.40% | 0.03% | -0.43% | -0.44% | -0.32% | -0.42% | -0.23% | -0.39% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $3M | · | $3M | $991.0K | $2M | $3M | $5M | $7M | $6M | $11M | $23M | |
| R&D Expense | $4M | $5M | $8M | $4M | $6M | $3M | $-10M | $5M | $7M | $22M | $28M | $25M | $30M | $24M | $25M | $20M | |
| SG&A Expense | $3M | $2M | $-1M | $2M | $3M | $1M | $-4M | $881.0K | $650.0K | $7M | $7M | $7M | $8M | $7M | $7M | $8M | |
| Operating Expenses | $7M | $7M | $7M | $6M | $9M | $4M | $-17M | $6M | $7M | $32M | $36M | $34M | $39M | $34M | $35M | $27M | |
| Operating Income | $-7M | $-7M | $-10M | $-6M | $-9M | $-4M | $14M | $-6M | $-7M | $-30M | $-33M | $-29M | $-32M | $-28M | $-24M | $-4M | |
| Interest Income | $200.0K | · | $100.0K | $300.0K | $100.0K | · | $100.0K | $200.0K | $200.0K | · | · | · | · | · | · | · | |
| Other Non-op | · | · | $0 | $0 | $13M | $347.0K | $-4M | $766.0K | $689.0K | $952.0K | $874.0K | $866.0K | $861.0K | $985.0K | $665.0K | $266.0K | |
| Income Tax | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-6M | $-7M | $-7M | $-6M | $4M | $-10M | $-13M | $-6M | $-7M | $-4M | $-32M | $-28M | $-31M | $-27M | $-23M | $-4M | |
| EPS (Basic) | $-0.69 | $-0.73 | $0.84 | $-0.59 | $0.51 | $-3.72 | $13.67 | $-2.14 | $-2.71 | $-20.24 | $-24.67 | $-0.52 | $-0.58 | $-0.49 | $-0.43 | $-0.08 | |
| EPS (Diluted) | $-0.69 | $-0.73 | $1.55 | $-0.59 | $-1.00 | $-3.72 | $13.67 | $-2.14 | $-2.71 | $-20.24 | $-24.67 | $-0.52 | $-0.58 | $-0.49 | $-0.43 | $-0.08 | |
| Shares (Basic) | 9,381,344 | 9,381,344 | · | 9,377,079 | 8,246,582 | 2,575,462 | · | 2,574,767 | 2,574,767 | 1,516,336 | · | 54,235,695 | 54,002,988 | 53,872,038 | 53,726,123 | 53,614,668 | |
| Shares (Diluted) | 9,381,344 | 9,381,344 | · | 9,377,079 | 8,455,223 | 2,575,462 | · | 2,574,767 | 2,574,767 | 1,516,336 | · | 54,235,695 | 54,002,988 | 53,872,038 | 53,726,123 | 53,614,668 | |
| EBITDA | $-7M | $-7M | · | $-6M | $-9M | $-2M | · | $-6M | $-17M | $-30M | · | $-29M | $-32M | $-28M | $-24M | $-4M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $20M | $21M | $21M | $21M | $34M | $32M | $37M | $49M | $47M | $52M | $63M | $58M | $47M | $43M | $47M | |
| Short-term Investments | · | $5M | $10M | $15M | $20M | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | $1M | · | $435.0K | $359.0K | $2M | $3M | $3M | · | · | · | · | |
| Inventory | · | · | · | · | · | $900.0K | · | $625.0K | $2M | $3M | $3M | $3M | $3M | $4M | $2M | $3M | |
| Prepaid Expense | $1M | $345.0K | $727.0K | $2M | $2M | $2M | $72.0K | $2M | $4M | $6M | $8M | $13M | $15M | $17M | $19M | $6M | |
| Current Assets | $17M | $25M | $32M | $38M | $43M | · | $32M | $48M | $64M | $81M | $116M | $101M | $125M | $143M | $187M | $176M | |
| PP&E (Net) | $36.0K | $44.0K | $52.0K | $60.0K | $68.0K | · | $84.0K | $3M | $3M | $4M | $3M | $1M | $308.0K | $368.0K | $487.0K | $549.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | |
| Intangibles | $291.0K | $306.0K | $322.0K | $338.0K | $354.0K | · | $385.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | · | $17.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $18M | $26M | $32M | $39M | $44M | $39M | $35M | $51M | $72M | $90M | $126M | $115M | $134M | $153M | $214M | $227M | |
| Accounts Payable | $5M | $5M | $3M | $4M | $2M | $4.0K | $2M | $3M | $7M | $5M | $12M | $8M | $12M | $4M | $15M | $10M | |
| Accrued Liabilities | $4M | $7M | $8M | $7M | $8M | · | $8M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $11M | $11M | $11M | $11M | $1M | $10M | $10M | $14M | $15M | $26M | $23M | $25M | $17M | $28M | $21M | |
| Capital Leases | $22.0K | $54.0K | $85.0K | $115.0K | $145.0K | · | $201.0K | · | $7M | $7M | $6M | $7M | · | · | $497.0K | $983.0K | |
| Total Liabilities | $9M | $11M | $11M | $11M | $11M | $47M | $41M | $51M | $61M | $60M | $69M | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $2.0K | $2.0K | $54.0K | $54.0K | $54.0K | $5.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | |
| Paid-in Capital | $132M | $132M | $131M | $131M | $131M | · | $1M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-124M | $-117M | $-110M | $-103M | $-98M | $-761M | $-92M | $-748M | $-735M | $-715M | $-685M | $-652M | $-624M | $-593M | $-536M | $-513M | |
| AOCI | · | $1.0K | $8.0K | $7.0K | $-13.0K | · | · | $-25.0K | $-121.0K | $-191.0K | $-260.0K | $-439.0K | $-730.0K | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $8M | $15M | $21M | $28M | $33M | $-8M | $-91M | $707.0K | $12M | $30M | $57M | $86M | $109M | $137M | $185M | $204M | |
| Liabilities + Equity | $18M | $26M | $32M | $39M | $44M | $39M | $35M | $51M | $72M | $90M | $126M | $115M | $134M | $153M | $214M | $227M | |
| Shares Outstanding | 9,381,344 | 9,381,344 | 9,381,344 | 9,379,332 | 9,373,433 | 1,524,535 | 2,574,767 | 54,846,639 | 54,837,764 | 54,667,079 | 4,540,059 | 54,471,829 | 54,068,806 | 53,974,352 | 53,733,607 | 53,710,300 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $23.0K | $24.0K | $24.0K | $24.0K | $47.0K | $24.0K | $24.0K | $-48.0K | $5.0K | $42.0K | $82.0K | $59.0K | $60.0K | $58.0K | $61.0K | $63.0K | |
| Stock-based Comp | $335.0K | $370.0K | $353.0K | $339.0K | $-719.0K | $80.0K | $79.0K | $-5M | $-3M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | |
| Deferred Tax | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | $0 | · | $707.0K | $3M | $2M | · | · | · | · | · | · | |
| Other Non-cash | · | $551.0K | · | · | · | $-1M | · | · | · | $-3M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $-9M | $-6M | $-6M | $-4M | $-9M | $-8M | $-5M | $29M | $24M | $-30M | $-17M | $-20M | $-20M | $-35M | $-25M | $-5M | |
| CapEx | · | · | · | · | · | · | · | $0 | $210.0K | $836.0K | $2M | · | · | · | $0 | $0 | |
| Investing Cash Flow | $5M | $5M | $5M | $5M | $-10M | $-11M | · | $2M | $15M | $26M | $-30M | $23M | $33M | $18M | $21M | $30M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | · | · | $1.0K | $-322.0K | $22M | $-2M | $27M | $1M | $690.0K | $-685.0K | $36M | $1M | $0 | $560.0K | $104.0K | $182.0K | |
| Net Change in Cash | $-4M | $-883.0K | $-684.0K | $770.0K | $9M | $-20M | $22M | $-7M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-31M | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -92.9% | · | -234.3% | -1746.3% | -1389.5% | · | -593.9% | -466.5% | -448.5% | -220.5% | -19.4% | |
| Net Margin | · | · | · | · | · | -191.0% | · | -488.1% | -2019.8% | -1437.8% | · | -576.1% | -454.0% | -432.5% | -214.4% | -18.3% | |
| EBITDA Margin | · | · | · | · | · | -92.9% | · | -234.3% | -1746.3% | -1387.5% | · | -593.9% | -466.5% | -447.6% | -220.5% | -19.4% | |
| ROA | -21.1% | -21.0% | · | -12.2% | 7.2% | -7.6% | · | -15.0% | -19.4% | -25.2% | · | -17.1% | -17.4% | -14.1% | -10.6% | -1.9% | |
| ROE | -31.3% | -211.6% | · | -38.7% | 18.7% | -45.1% | · | -28.9% | -33.2% | -36.9% | · | -20.7% | -20.1% | -15.7% | -11.8% | -2.1% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.2 | · | 3.5 | 4.0 | · | · | 4.8 | 4.6 | 5.4 | · | 4.4 | 4.9 | 8.6 | 6.6 | 8.3 | |
| Quick Ratio | 1.7 | 2.2 | · | 3.3 | 3.8 | 29.6 | · | 3.7 | 3.6 | 3.2 | · | 2.9 | 2.3 | 2.8 | 1.5 | 2.2 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Receivables Turnover | · | · | · | · | · | 1.7 | · | 1.4 | 5.5 | 2.5 | · | 2.9 | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.89 | $1.55 | · | $2.97 | $3.51 | $-5.30 | · | $0.01 | $0.21 | $0.55 | · | $1.57 | $2.01 | $2.53 | $3.44 | $3.81 | |
| Revenue / Share | · | · | · | · | · | $1.69 | · | $0.05 | $0.02 | $0.04 | · | $0.09 | $0.13 | $0.11 | $0.20 | $0.43 | |
| Cash Flow / Share | · | $-0.62 | · | · | · | $-3.08 | · | · | · | $-0.56 | · | · | · | $-0.64 | · | · | |
| Cash / Share | $1.68 | $2.12 | · | $2.28 | $2.20 | $22.44 | · | $0.68 | $0.90 | $0.86 | · | $1.15 | $1.08 | $0.88 | $0.80 | $0.87 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.46 | $-0.77 | · | $8.36 | $6.81 | $5.10 | · | $-49.76 | $-48.14 | $-46.01 | · | $-19.68 | $-19.59 | $-19.09 | $-1.67 | $-1.26 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $9M | $11M | $17M | · | $21M | $27M | $43M | $39M | $49M | |
| Net Income TTM | $-26M | $-15M | · | $-24M | $-24M | $-35M | · | $-49M | $-72M | $-96M | · | $-117M | $-112M | $-84M | $-89M | $-66M | |
| Market Cap | $18M | $30M | · | $366M | $219M | $23M | · | $608M | $509M | $1.79B | · | $3.29B | $5.51B | $9.54B | $18.11B | $17.65B | |
| P/E | -4.1 | -4.1 | · | 4.7 | 3.4 | 3.0 | · | -0.2 | -0.2 | -0.7 | · | -3.1 | -5.2 | -9.3 | -201.8 | -260.9 | |
| P/S | · | · | · | · | · | · | · | 70.0 | 46.3 | 105.7 | · | 155.2 | 202.7 | 220.6 | 459.2 | 361.1 | |
| P/B | 2.1 | 2.1 | · | 13.1 | 6.6 | -2.9 | · | 860.2 | 43.9 | 60.1 | · | 38.5 | 50.6 | 69.8 | 98.0 | 86.4 | |
| P / Tangible Book | 2.2 | 2.1 | · | 13.3 | 6.7 | · | · | 860.2 | 43.9 | 60.1 | · | 38.5 | 50.6 | 69.8 | 98.0 | 86.4 | |
| P / Cash Flow | · | -5.1 | · | · | · | -4.9 | · | · | · | -58.8 | · | · | · | -275.6 | · | · | |
| Earnings Yield | -24.2% | -24.2% | · | 21.4% | 29.2% | 33.5% | · | -448.8% | -518.3% | -140.5% | · | -32.5% | -19.2% | -10.8% | -0.50% | -0.38% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | · | $7M | $21M | $42M | $23M |
| 营业利润率 % | · | -818.0% | -579.4% | -209.1% | -386.9% |
| 净收入 | $-18M | $-29M | $-119M | $-85M | $-88M |
| 稀释后每股收益 (EPS) | $-3.26 | $-11.42 | $-26.26 | $-19.12 | $-1.74 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 2.9 | 11.0 | 4.5 | 7.2 | 9.8 |
| 速动比率 | 2.8 | 9.6 | 2.1 | 2.7 | 0.8 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | · | $-62M | $-94M | $-79M | $-60M |
机构持有人 (13F) 60 家申报者 · $6.1M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
60
持有价值
$6.1M
新仓位
12
已退出持仓
19
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 12 (-3 与上一季度对比) | 19 (+7 与上一季度对比) | 7 (-12 与上一季度对比) | 24 (+8 与上一季度对比) | -455K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Vifor (International) Ltd., CSL Limited ×3 申报 | 2025年4月16日 | 2.20% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 34 位内幕人士 · 18 位高管 · 17 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Imran Nizamudin Alibhai | Chief Executive Officer | 2026年1月29日 A | · | 0 | 0 | $0 |
| Christopher Posner | PRESIDENT AND CEO | 2025年2月28日 S | 13109 | 0 | 0 | $0 |
| Derek T Chalmers | President & CEO | 2021年9月7日 S | 991405 | 0 | 0 | $0 |
| Avi Daniel Conn | Chief Financial Officer | 2026年1月29日 A | · | 0 | 0 | $0 |
| Ryan D Maynard | CHIEF FINANCIAL OFFICER | 2023年2月8日 S | 8012 | 0 | 0 | $0 |
| Mani Mohindru | CFO & Chief Strategy Officer | 2019年12月4日 S | 17441 | 0 | 0 | $0 |
| Josef Schoell | Chief Financial Officer | 2017年7月26日 M | 50000 | 0 | 0 | $0 |
| Stephen Paul O'Brien | Principal Accounting Officer | 2026年1月29日 A | · | 0 | 0 | $0 |
| John Saewook Kauh M.D. | Chief Medical Officer | 2026年1月29日 A | · | 0 | 0 | $0 |
| Yixin Chen | VP, Chem, Mfg and Ctrls | 2025年4月17日 A | · | 0 | 0 | $0 |
| Jeffrey Leroy Larson | SVP, Research & Development | 2025年4月17日 A | · | 0 | 0 | $0 |
| Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | 2025年2月28日 S | 7190 | 0 | 0 | $0 |
| Joana Goncalves | CHIEF MEDICAL OFFICER | 2024年4月5日 S | 53365 | 0 | 0 | $0 |
| Frederique Menzaghi Ph.D. | CHIEF SCIENTIFIC OFF,SVP-R&D | 2024年2月1日 A | 167247 | 0 | 0 | $0 |
| Richard Makara | VP, Head of Accting;Controller | 2022年6月15日 A | 13583 | 0 | 0 | $0 |
| Joseph William Stauffer | Chief Medical Officer | 2018年10月17日 S | 2000 | 0 | 0 | $0 |
| Michael E Lewis | Chief Scientific Advisor | 2017年3月8日 A | 314988 | 0 | 0 | $0 |
| Robert Medve | Chief Medical Officer | 2014年6月17日 A | · | 0 | 0 | $0 |
| Susan Shiff Ph.D. | 董事 | 2026年6月9日 A | 202085 | 0 | 0 | $0 |
| Wallace L Hall JR | 董事 | 2026年6月9日 A | 202044 | 0 | 0 | $0 |
| Cynthia Smith | 董事 | 2026年6月9日 A | · | 0 | 0 | $0 |
| Sujal Shah | 董事 | 2026年6月9日 A | · | 0 | 0 | $0 |
| Michael S Wyzga | 董事 | 2026年6月9日 A | · | 0 | 0 | $0 |
| Shaheen Wirk | 董事 | 2025年4月15日 A | 263164 | 0 | 0 | $0 |
| Lisa Von Moltke | 董事 | 2024年6月4日 A | 183009 | 0 | 0 | $0 |
| Helen M Boudreau | 董事 | 2024年6月4日 A | 150647 | 0 | 0 | $0 |
| Jeffrey L. Ives | 董事 | 2024年6月4日 A | 198485 | 0 | 0 | $0 |
| Martin Vogelbaum | 董事 | 2024年6月4日 A | 411007 | 0 | 0 | $0 |
| Harrison M Bains JR | 董事 | 2023年6月1日 A | 57438 | 0 | 0 | $0 |
| Dean Slagel | 董事 | 2017年6月29日 S | 1064338 | 0 | 0 | $0 |
| Charles Moller Ph.D. | 董事 | 2014年2月5日 C | 1576404 | 0 | 0 | $0 |
| Edward Hurwitz | 董事 | 2014年1月30日 A | · | 0 | 0 | $0 |
| Samuel David Tweardy | 10% 所有者 | 2025年7月7日 J | 0 | 0 | 0 | $0 |
| Thomas Charles Reilly | · | 2022年3月3日 S | 37811 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 2 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
TVRD 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 15 位分析师
买入
中位数目标
$10.00
+963.8%
4 26.7%
强烈买入
8 53.3%
买入
2 13.3%
持有
1 6.7%
卖出
0 0.0%
强烈卖出
12个月价格目标
9 位分析师 · 2026-10-23平均目标 $9.11 +869.3%
← 低于所有目标
当前价格 $0.94
最低$3.00
平均值$9.11
最高$14.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 14, 2026 申报